PRECLINICAL INVESTIGATION OF THE INFLUENCE OF B. SUBTILIS IMV B-7724 LECTIN ON THE DYNAMICS OF MACROPHAGES FUNCTIONAL ACTIVITY AFTER TRANSPLANTATION OF CHEMOSENSITIVE OR CHEMORESISTANT EXPERIMENTAL TUMORS
DOI:
https://doi.org/10.32471/oncology.2663-7928.t-23-1-2021-g.9409Keywords:
bacterial lectin, chemoresistance, doxorubicin, M1 and M2 type macrophages, Walker carcinosarcoma 256Abstract
Aim: to determine the indicators of peritoneal Mph’s functional activity in rats in the dynamics of growth of different Walker carcinosarcoma 256 strains characterized by diverse sensitivity to doxorubicin under the use of doxorubicin or lectin B. subtilis INV B-7724. Object and methods: in the investigation, Wistar rats were used. Sensitive and doxorubicin-resistant (DOX) strains of Walker carcinosarcoma 256 were used as models of tumor growth. DOX was used as the means of chemotherapy; lectin of B. subtilis IMV B-7724 was applied as an immunotherapy. The functional state of peritoneal macrophages (Mph) was assessed based on nitric oxide (NO) production and arginase (Arg) activity; the NO/Arg ratio was calculated. Statistical analyses of the results was done according to generally accepted methods of variation statistics. Results: Regardless of which strain of Walker carcinosarcoma 256 (wild type or DOX-chemoresistant) was transplanted, application of immunotherapy means impede the tumors growth. In the rats transplanted with the doxorubicin-resistant strain of carcinosarcoma Walker 256, decrease in the Mph’s ability to produce NO and increase in arginase activity were the most pronounced: the NO/Arg ratio was 1.8 times (p <0.05) lower than in the intact rats and 1.3 times lower (p < 0.05) comparing with the group of animals bearing the wild strain of the carcinosarcoma. In rats bearing carcinosarcoma, application of bacterial lectin as a means of immunotherapy led to a significant increase in NO production by peritoneal Mph and to a decrease in theirs Arginase activity independently of the tumor sensitivity to chemotherapy. Conclusions: the growth of carcinosarcoma Walker 256 is accompanied with a significant inhibition of Mph antitumor activity. This effect is more pronounced in rats bearing the DOX-resistant strain of the tumor. Application of B. subtilis IMV B-7724 lectin helped to preserve Mph’s type M1 functional phenotype till the late terms of tumor progression, regardless of the experimental tumor’s chemoresistance.
References
Ji X, Lu Y, Tian H, et al. Chemoresistance mechanisms of breast cancer and their countermeasures. Biomed Pharmacother 2019; 114: 108800.
Christowitz C, Davis T, Isaacs A, et al. Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model. BMC Cancer 2019; 19: 757.
Micallef I, Baron B. Doxorubicin: an overview of the anti-cancer and chemoresistance mechanisms. Ann Clin Toxicol 2020; 3 (2): 1031.
Mills CD. Anatomy of a discovery: M1 and M2 macrophages. Front Immunol 2015; 6: 212.
Ruffell B, Coussens LM. Macrophages and therapeutic resistance in cancer. Cancer Cell 2015; 27 (4): 462–72.
Dudas J, Ladanyi A, Ingruber J, et al. Epithelial to mesenchymal transition: a mechanism that fuels cancer radio/chemoresistance. Cells 2020; 9 (2): 428.
Sun D, Luo T, Dong P, et al. M2-polarized tumor-associated macrophages promote epithelial-mesenchymal transition via activation of the AKT3/PRAS40 signaling pathway in intrahepatic cholangiocarcinoma. J Cell Biochem 2020; 121 (4): 2828–38.
O’Sullivan T, Saddawi-Konefka R, Vermi W, et al. Cancer immunoediting by the innate immune system in the absence of adaptive immunity. J Exp Med 2012; 209 (10): 1869–82.
Larionova I, Cherdyntseva N, Liu T, et al. Interaction of tumor-associated macrophages and cancer chemotherapy. Oncoimmunology 2019; 8 (7): 1596004.
D’Alterio C, Scala S, Sozzi G, et al. Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion. Semin Cancer Biol 2020; 60: 351–61.
Cancer in Ukraine, 2019–2020. Incidence, mortality, prevalence and other relevant statistic. Bull Natl Cancer Register Ukr; Kyiv, 2021; 22: http://www.ncru.inf.ua/publications/BULL_22. (in Ukrainian)
Pilco-Ferreto N, Calaf GM. Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines. Int J Oncol 2016; 49 (2): 753–62.
Zhao M, Ding XF, Shen JY, et al. Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice. J Zhejiang Univ Sci 2017; 18 (1): 15–26.
Pritchard JE, Dillon PM, Conaway MR, et al. A mechanistic study of the effect of doxorubicin/adriamycin on the estrogen response in a breast cancer model. Oncology 2012; 83 (6): 305–20.
Santos JVdO, Porto ALF, Cavalcanti IMF. Potential application of combined therapy with lectins as a therapeutic strategy for the treatment of bacterial infections. Antibiotics 2021; 10 (5): 520.
Oliveira Brito PKM, Gonçalves TE, Fernandes FF, et al. Systemic effects in naïve mice injected with immunomodulatory lectin ArtinM. PLoS One 2017; 12 (10): e0187151.
Mishra A, Behura A, Mawatwal S, et al. Structure-function and application of plant lectins in disease biology and immunity. Food Chem Toxicol 2019; 134: 110827.
Podgorskii VS, Kovalenko ÉA, Karpova IS, et al. Extracellular lectins from saprophytic strains of bacteria of the genus Bacillus (review). Prikl Biokhim Mikrobiol 2014; 50 (3): 256–63. (in Russian)
do Amaral LA, de Souza GHO, Santos MR, et al. Walker-256 tumor: experimental model, implantation sites and number of cells for ascitic and solid tumor development. Braz Arch Biol Technol 2019, 62 (12): e19180284.
Shenoy PA, Kuo A, Vetter I, Smith MT. The Walker 256 breast cancer cell-induced bone pain model in rats. Front Pharmacol 2016; 7: 286.
Boroday NV, Chekhun VF. Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells. Exp Oncol 2018, 40 (1): 42–7.
Todor IN, Lukianova NYu, Shvets YuV, et al. Metabolic changes during developmentof Walker-256 carcinosarcoma resistance to Doxorubicin. Exp Oncol 2015, 37 (1): 19–22.
Kozhemyakin UM, Filonenko MA, Saifetdinova GA. Scientific and Practical Recommendations for Keeping Laboratory Animals and Working with Them. K: Avicenna 2002; 156 p (in Ukrainian).
Podgorsky VS. The method for the obtainmen of bacterial lectin, specific to sialic acids (Pat. № 1791 UA). Publ. 23.01.1991. Bul. № 1. (in Ukrainian)
Fedosova NI, Cheremshenko NL, Hetman KI, et al. Physical-chemical and cytotoxic properties of Bacillus subtilis IMV B-7724 extracellular lectin. Mikrobiol Z 2021; 83 (1): 39–48.
Chumak A, Shcherbina V, Fedosova N, Chekhun V. Polarization of macrophages of mice under the influence of lectin from Bacillus Subtilis IMV B-7724. EUREKA: Life Science 2021; (3): 3–10.
Reiner NE. Methods in molecular biology. Macrophages and dendritic cells. Methods and protocols. Preface. Methods Mol Biol 2009; 531: v-vi. doi: 10.1007/978–1-59745–396–7.
Corraliza IM, Campo ML, Soler G, Modolell M. Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 1994; 174 (1–2): 231–5.
Dovgiy RS, Shitikov, D.V., Pishel, I.N., et al. Functional state and metabolic polarization of splenic macrophages of old immunized mice. Problemy stareniya i dolgoletiya 2015; 24 (2): 147. (in Russian)
Sidenko AB, Vishnyakov VV, Isaev SM. Theory of statistics. М: MAX-Press, 2011. 343 p. (in Russian)
Rath M, Müller I, Kropf P. Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages. Front Immunol 2014, 5: 532.
